Oncology Animations

Researchers Identify Key Enzyme In DNA Repair Pathway
Researchers have discovered an enzyme crucial to a type of DNA repair that also causes resistance to a class of cancer drugs most commonly used against ovarian cancer...

Belly Button Surgery For Kidney Cancer
Surgeons at the University of California, San Diego School of Medicine continue to advance minimally-invasive surgery for cancer patients by reducing the number of abdominal incisions from approximately six to a single small incision...

Allos Therapeutics Announces Topline Results From Phase 2b Study Of FOLOTYN In Patients With Advanced Non-Small Cell Lung Cancer
Allos Therapeutics, Inc. (NASDAQ:ALTH) announced topline results from the Company's randomized Phase 2b investigational trial of FOLOTYN® (pralatrexate injection) versus erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC) who had received one or two prior systemic treatments including at least one prior platinum-based regimen...

ArQule Announces Initiation By Kyowa Hakko Kirin Of Phase 2 Clinical Trial In Asia With ARQ 197 In Gastric Cancer
ArQule, Inc. (Nasdaq: ARQL) announced the initiation of a Phase 2, single agent trial with ARQ 197 in gastric cancer by Kyowa Hakko Kirin, its exclusive licensee for the development and commercialization of ARQ 197 in the Asian territory consisting of Japan, China (including Hong Kong), South Korea and Taiwan...

Fecal Blood Test More Cost Efficient Than Colonoscopy At Detecting Colorectal Cancers
While colonoscopies are the most accurate method for the early detection of colorectal cancers, screening with fecal occult blood tests results in more efficient use of limited budgets, according to a new study by researchers at RTI International...

It's Time: Bowel Cancer Screening Cannot Wait For A Fourth Election
Australia's next government must close a yawning gap in the nation's cancer control response by committing now to fully implementing the National Bowel Cancer Screening Program before more lives are lost unnecessarily, Cancer Council Australia said today...

Etubics Enters Phase I Cancer Clinical Trials Focused On Colorectal Cancer
Etubics Corporation, a biopharmaceutical company developing "next generation" vector vaccines, has entered into Phase I trials at Duke University with its ETBX-011, a therapeutic vaccine candidate that is intended to treat Carcinoembryonic Antigen (CEA)-expressing cancers such as colorectal cancer. Etubics dosed its first patient yesterday. Etubics was recently granted clearance by the U.S...

Biology, Computer Science Combine Efforts To Fight Cancer
The University of Houston (UH) received a $2.4 million grant to fund the most promising young cancer researchers who are working at the cutting-edge of a new multidisciplinary approach to fighting cancer. The award is part of the latest round of grant disbursements from the Cancer Prevention and Research Institute of Texas (CPRIT), which oversees the state's new billion-dollar war on cancer...

NCCN Receives $4 Million In Oncology Research Funding From GlaxoSmithKline
The National Comprehensive Cancer Network (NCCN) has been awarded two individual $2 million grants from GlaxoSmithKline (GSK) to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors...

New Surgery Without Incisions Shows Promise For Prostate Cancer Treatment
With a recent first of its kind surgery, physicians at Mayo Clinic in Arizona have developed a new surgical procedure for the treatment of prostate cancer using natural orifices - signaling the next step in the evolution of minimally invasive surgery. Removing the prostate is a common treatment for patients with prostate cancer, which affects one in six men in the U.S...

Abraxis BioScience And Specialised Therapeutics Announce Approval To Market ABRAXANE For Metastatic Breast Cancer In New Zealand
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, and Specialised Therapeutics Ltd. today announced that MEDSAFE, the New Zealand Medicines and Medical Devices Safety Authority, has approved for marketing ABRAXANE® (nanoparticle albumin-bound paclitaxel) for the treatment of metastatic breast cancer after failure of anthracycline therapy...

Research On Enzyme For Activating Promising Disease-Fighters Co-Authored By Middle School Students
Grown-ups aren't the only ones making exciting scientific discoveries these days. Two middle school students from Wisconsin joined a team of scientists who are reporting the first glimpse of the innermost structure of a key bacterial enzyme. It helps activate certain antibiotics and anti-cancer agents so that those substances do their job. Their study appears in ACS' weekly journal Biochemistry...

Dense Bones Linked To Raised Risk For Prostate Cancer
Men who develop prostate cancer, especially the more aggressive and dangerous forms that spread throughout the body, tend to retain denser bones as they age than men who stay free of the disease, suggests new research from Johns Hopkins and the National Institute on Aging (NIA), part of the National Institutes of Health...

Bid To Aid Transplant Cancer Patients
Organ transplant patients who develop cancer may be helped by a treatment that uses blood cells to attack their tumour. University of Edinburgh researchers have generated a bank of white blood cells from healthy blood donors to treat patients with a blood cancer called post transplant lymphoproliferative disease (PTLD)...

Breakthrough Breast Cancer Identifies Potential New Treatment Which Could Help 800 Scottish Women Each Year
Scientists from the Breakthrough Breast Cancer Research Unit at the University of Edinburgh have discovered a potential new way to treat a common form of breast cancer which affects 800 Scottish women and 9,000 UK women each year. The team are the first to identify a gene's key role in causing the spread of HER2 positive breast cancer to other parts of the body...